SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-17-001057
Filing Date
2017-02-28
Accepted
2017-02-28 16:17:11
Documents
78
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2230992z10-k.htm 10-K 1290769
2 EX-10.72 a2230992zex-10_72.htm EX-10.72 40194
3 EX-21.1 a2230992zex-21_1.htm EX-21.1 4686
4 EX-23.1 a2230992zex-23_1.htm EX-23.1 7046
5 EX-31.1 a2230992zex-31_1.htm EX-31.1 8364
6 EX-31.2 a2230992zex-31_2.htm EX-31.2 8387
7 EX-32 a2230992zex-32.htm EX-32 6998
14 G357955.JPG g357955.jpg GRAPHIC 79605
  Complete submission text file 0001047469-17-001057.txt   8758345

Data Files

Seq Description Document Type Size
8 EX-101.INS inva-20161231.xml EX-101.INS 2278568
9 EX-101.SCH inva-20161231.xsd EX-101.SCH 66775
10 EX-101.CAL inva-20161231_cal.xml EX-101.CAL 71286
11 EX-101.DEF inva-20161231_def.xml EX-101.DEF 263414
12 EX-101.LAB inva-20161231_lab.xml EX-101.LAB 653643
13 EX-101.PRE inva-20161231_pre.xml EX-101.PRE 467630
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 17647872
SIC: 2834 Pharmaceutical Preparations